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During the 97th General Session and Exhibition of the IADR, the IADR Council adopted policy 
and position statements on the safety of dental amalgam (American Association for Dental Research  
2019). The policy development process is overseen by the IADR Science Information Committee (SIC). 
While recognizing its global audience, the IADR SIC policy development process is identical to that of 
IADR’s American division (AADR) and has been previously described (Ajiboye et al. 2018).  
The policy statement on the safety of dental amalgam is a succinct affirmation of the 
Association’s evidence-based assessment, whereas the position statement is a fuller review of the 
scientific evidence. These statements were timely for the Third Conference of the Parties (COP-3) to 
the Minamata Convention on Mercury, an international treaty aimed at reducing global mercury 
pollution caused by human activity. In 2010, the United Nations Environmental Program estimated that 
dental amalgam contributed 21-32% and 19-13% of overall air and surface water emissions, respectively, 
in Europe. However, the total contribution of dental amalgam to mercury pollution is unknown and 
likely varies by region depending on a number of factors, such as other sources of mercury pollution; 
prevalence of use of dental amalgam compared to other materials; access to dental care and waste 
management and cremation practices. Emissions from dental amalgam can result from preparation and 
removal of dental amalgam, disposal, waste, cremation, etc. While it is estimated that mercury emission 
to air from cremation accounts for ~0.25% of the total, emissions from the other processes associated 
with use from dental amalgam have not been quantified (UN Environment 2019).  
While the treaty requires the phase-out of many mercury-added products (with exceptions for 
products used for military use, research, religious practices, vaccines and for which there is no suitable 
alternative), the parties agreed to a phase-down of dental amalgam – Annex A Part II (Minamata 
Convention on Mercury: Text and Annexes  2017) – since there was not at the time – and is not 
currently – a replacement material that is as inexpensive, easy to handle and most importantly, durable 
as dental amalgam. The treaty development process, negotiations and the role of the dental research 
community were reviewed in Meyer et al (Meyer et al. 2016). IADR is committed to (a) placing 
 
increased emphasis on research into primary prevention and behavior change strategies that will reduce 
the prevalence of dental caries and (b) promoting research into new dental materials that could one day 
replace dental amalgam entirely. 
In November 2019, the parties considered a proposal to phase out dental amalgam by 2024 
except where no alternative is available. IADR worked with FDI World Dental Congress, American 
Dental Association and International Dental Manufacturers and conducted meetings with U.S. delegates 
to the conference from the U.S. State Department and Environmental Protection Agency. IADR also 
submitted a research report to the treaty secretariat that showed that although research on alternative 
restorative materials was advancing, new materials were still not completely developed and would not 
be optimal replacements for dental amalgam in all situations for clinical, economic or practical reasons 
(International Association for Dental Research  2019). Since the adoption of these statements, the U.S. 
Food and Drug Administration published an updated systematic literature review, which concluded, 
“Overall, although exposure to elemental mercury at sufficiently high levels, e.g., chlor-alkali workers, is 
associated with adverse human health effects, the current evidence is insufficient to support a causal 
association between mercury from dental amalgam and reported adverse health effects. This is 
consistent with the assessments of other scientific organizations such as the recent [Scientific 
Committee on Emerging and Newly Identified Health Risk] report which concluded that dental amalgam 
does not pose a health risk for the general population, and the currently available evidence neither 
precludes the use of amalgam in dental restorations nor suggests the need for preventive removal of 
pre-existing amalgam restorations” (U.S. Food and Drug Administration 2019). Further, a recent analysis 
from the United Kingdom suggests a complete phase down of dental amalgam threatens to widen oral 
health inequalities (Aggarwal et al. 2019). 
As a result of these efforts and those by other countries, the parties agreed to maintain the 
original provision while encouraging parties to increase phase-down efforts. COP-4 will be held in 2021. 
In the intervening time, dental associations will work to gather information on the use of dental 
 
amalgam, comparative effectiveness of dental amalgams and alternatives and other information on the 
progress of implementing the provision. 
 
Policy statement on the Safety of Dental Amalgam  
Based on the best available evidence, IADR affirms the safety of dental amalgam for the general 
population without allergies to amalgam components or severe renal diseases. IADR supports 
maintaining its availability as the best restorative option when alternatives are less than optimal based on 
clinical, economic or practical reasons. 
IADR supports the phase-down strategy described in the Minamata Convention on Mercury. 
Consistent with the recommendations of the treaty, IADR emphasizes the need, firstly, for increased 
oral disease prevention efforts to reduce the need for any kind of restorative material, and secondly, for 
further research on new biocompatible and environmentally-friendly restorative materials and 
approaches that are proven to have equal or improved long term clinical longevity and cost effectiveness 
when compared to amalgam restorations. 
 
Position statement on the Safety of Dental Amalgam 
 
Introduction 
IADR affirms the safety of dental amalgam for the general population without allergies to 
amalgam components or severe renal diseases. IADR supports maintaining its availability as the best 
restorative option when alternatives are less than optimal based on clinical, economic or practical 
reasons. The safety of dental amalgam has been investigated and affirmed through independent 
systematic reviews of the available scientific literature conducted by national and global scientific 
organizations, including the European Union (EU) Scientific Committee on Emerging and Newly 
Identified Health Risks (SCENIHR), World Health Organization (WHO) and the U.S. Food and Drug 
 
Administration (FDA). The last review identified was conducted by SCENIHR and summarized studies 
performed up to 2014. This position statement considers evidence identified in previous reviews and 
after 2014 regarding the safety of dental amalgam for use in general and vulnerable populations and by 
dental health providers.  
 
The composition and clinical effectiveness of dental amalgams   
Dental amalgam is an alloy of metals that comprises approximately 50% mercury and silver, tin, 
copper and other metals. Dental amalgam was the first durable dental material that could be placed 
directly into teeth with dental caries and has been in use for over 150 years. Liquid mercury gives dental 
amalgam its malleability, enabling the dentist to shape and place the material into the tooth before it 
hardens (Ferracane 2001). Dental amalgam is less expensive (CADTH 2018) and easier to place 
compared to the most popular alternative material – tooth-colored composite resin. Currently, the use 
of amalgam varies country-by-country and is driven by clinical, economic and practical reasons (Eltahlah 
et al. 2018). Composite resin fillings in permanent teeth in the back of the mouth are twice as likely to 
fail and carry a higher risk of secondary tooth decay compared to amalgam fillings, especially in children. 
Secondary decay occurs in the tooth after the restoration is placed and is the most common reason that 
restorations fail (Bernardo et al. 2007; CADTH 2018; Rasines Alcaraz et al. 2014; Soncini et al. 2007). 
 
No established links between amalgam and systemic diseases  
Many health-related concerns surrounding the safety of using mercury-containing materials in 
the mouth have arisen. However, the totality of available evidence is not sufficient to suggest a systemic 
health risk associated with dental amalgam use in the general population. This is the position of both the 
FDI World Dental Federation (FDI) and World Health Organization (WHO), which consider the use of 
dental amalgam to be safe, with risk related only to local irritations and not to systemic adverse health 
effects (WHO Consensus Statement on Dental Amalgam  1997). The U.S. FDA found insufficient 
 
evidence for a link between mercury exposure from dental amalgam and adverse systemic health effects, 
including in vulnerable populations. The FDA reviewed data on children and pregnant and breastfeeding 
women and available studies on a variety of diseases, including multiple sclerosis, Alzheimer’s Disease,  
and other neurological diseases; low birth weight; and cardiovascular disease (National Center for 
Toxicological Research and U.S. Food and Drug Administration 2009). Likewise, after reviewing several 
adverse health effects on neurological, immunological, and reproductive systems in the general 
population, SCENIHR concluded that dental amalgam fillings were not linked to systemic diseases in the 
general population (Scientific Committee on Emerging and Newly Identified Health Risks 2015). 
 
Low levels of mercury released from dental amalgam 
While it is true that those with dental amalgam fillings generally have higher levels of blood and 
urine mercury levels, it is important to note that slight increases in mercury exposure due to dental 
amalgam do not rise to a level of concern and are not expected to lead to adverse health effects. The 
expected exposure to mercury from dental amalgam is well below the EU safety limits established for 
those occupationally exposed to mercury (Scientific Committee on Emerging and Newly Identified 
Health Risks 2015). The U.S. Agency for Toxic Substances and Disease Registry (ATSDR) established a 
minimum risk level (MRL) for chronic inhalation of mercury vapor of approximately 4 micrograms 
inhaled mercury per day, which is less than people in the U.S. and Canada are exposed to from their 
amalgam fillings. The MRL is the level of mercury that can be inhaled without the expectation of suffering 
adverse health effects. Exposure to a higher level of mercury vapor does not necessarily mean the 
exposed would suffer adverse health effects but that at the MRL, no adverse effect is expected. This 
value takes into account infants, older people and people with poor health (Agency for Toxic Substance 
and Disease Registry and Public Health Service 1999). The U.S. Environmental Protection Agency (EPA) 
 
derived a similar risk estimate of 6 micrograms per day (National Center for Environmental Assessment  
1995).1 
The amount of mercury released from amalgam restorations is likely dependent on a number of 
factors including the number of restorations, the surface area of the restorations, chewing and brushing 
habits and the ages of the restorations (Agency for Toxic Substance and Disease Registry and Public 
Health Service 1999; National Center for Toxicological Research and U.S. Food and Drug 
Administration 2009). Urine levels of mercury increase by approximately 1-2 units in adults for every 10 
amalgam fillings placed (Dye et al. 2005). Furthermore, the amount of mercury released from amalgam 
fillings decreases over time (Berdouses et al. 1995; DeRouen et al. 2006; Palkovicova et al. 2008).  
 
Amalgam removal 
Some patients have had their amalgam fillings removed out of unfounded health concerns. 
However, amalgam fillings should not be removed except in the case of an allergic reaction (Agency for 
Toxic Substance and Disease Registry and Public Health Service 1999; Scientific Committee on Emerging 
and Newly Identified Health Risks 2015). Patients who had their amalgam fillings removed did not 
experience a meaningful decrease in blood mercury levels even years after the removal (National Center 
for Toxicological Research and U.S. Food and Drug Administration 2009). Most studies showed patients 
did not receive symptomatic relief after removal. In some studies, symptoms did not correlate with the 
number of amalgam fillings or exposure to mercury, meaning that their symptoms were likely not due to 
their fillings in the first place. Furthermore, the experience of negative life events made it difficult to 
attribute symptoms to their amalgam fillings (Agency for Toxic Substances and Disease Registry 2003; 
Scientific Committee on Emerging and Newly Identified Health Risks 2015). 
  
                                                             
1 The MRL derived by ATSDR is for noncancer health effects as is the risk estimate by the U.S. EPA. The EPA 
assessed potential cancer-causing effects of inhalation of elemental mercury – the type of mercury released by 
dental amalgam – and did not find enough evidence to draw a conclusion. 
 
Vulnerable populations 
There is particular concern around the use of dental amalgam in vulnerable populations, 
particularly in children and pregnant and breastfeeding women. The systematic reviews performed by 
the FDA and SCENIHR included studies on these populations. Both the FDA and SCENIHR reviews 
found that fetal exposure to mercury from dental amalgam correlated with the number of maternal 
fillings but that exposure decreases after birth even with breastfeeding. Fetal exposure to mercury from 
maternal dental amalgam restorations is below the “level considered to be hazardous for 
neurodevelopmental effects in children exposed to [mercury] in utero” (Palkovicova et al. 2008); the 
more time since the mother’s last filling, the less mercury to which the fetus is exposed; and most 
importantly, has not been linked to adverse health effects in children exposed to mercury from dental 
amalgam in the womb (National Center for Toxicological Research and U.S. Food and Drug 
Administration 2009; Scientific Committee on Emerging and Newly Identified Health Risks 2015).  
Two studies are particularly notable. The National Institute of Dental and Craniofacial Research 
funded two studies in Portugal and the U.S. to determine if there were any adverse health effects in 
children whose teeth were restored with dental amalgam. Both studies were randomized clinical trials 
and were conducted over seven and five years, respectively. In each study, over 500 children were 
randomly assigned to group receiving either amalgam or composite resin fillings. As expected, both 
studies showed that children with amalgam restorations had higher levels of mercury in their urine 
compared to children treated with composite resin (Bellinger et al. 2006; DeRouen et al. 2006). In the 
Portugal study, urinary mercury levels plateaued by the second year of the study and declined 
throughout the rest of the study. Furthermore, there was no statistical difference between children in 
the amalgam or composite resin groups in behavioral tests, including memory and attention, at any point 
during this study. Children whose teeth were restored with composite resin in this study also 
experienced more failure of their tooth restorations, congruent with previous observations (Bernardo 
et al. 2007; DeRouen et al. 2006; Soncini et al. 2007). In the study conducted in the U.S., there was also 
 
no statistical difference between children treated with dental amalgam and composite resin in 
neurological tests, including for IQ and memory, or kidney function (Bellinger et al. 2006). 
Since 2014, studies on pregnant women and children showed increased mercury in urine and 
blood of children and pregnant women with dental amalgam fillings, as expected (Baek et al. 2016; 
Golding et al. 2016); no statistically significant association between maternal amalgam restorations and 
stillbirth after accounting for maternal parameters such as age and smoking, among others (Lygre et al. 
2016); higher maternal and cord blood in mothers with amalgam restorations but no difference in birth 
weight, length or head circumference (Bedir Findik et al. 2016) and no increased risk of child mortality 
or neurological disorders of the sons of female dental staff (Naimi-Akbar et al. 2014; Vähäsarja et al. 
2016). 
The SCENIHR review did recommend alternative restorative materials for the primary teeth of 
children and the teeth of pregnant women, but this recommendation was made to comply with the 
provisions of the Minamata Convention on Mercury to address environmental concerns (see section, 
“Mercury and the Environment – the Minamata Convention”) (Scientific Committee on Emerging and 
Newly Identified Health Risks 2015).  
It is, however, well recognized that amalgam should not been used in patients with a verified 
contact allergy to amalgam or its components (Thanyavuthi et al. 2016). Furthermore, the SCENIHR 
reports draws attention to the fact that amalgams should not be the restoration of choice for patients 
with severe renal diseases as mercury excretion is impaired in this cohort. 
 
Occupational safety issues and dental amalgams 
Another concern is the occupational safety of using dental amalgam. Dental professionals who 
place dental amalgam are exposed to more mercury than the general population, although exposure 
should be decreasing due to the use of encapsulated dental amalgam and increased awareness and 
precautions when handling dental amalgam (National Center for Toxicological Research and U.S. Food 
 
and Drug Administration 2009; Scientific Committee on Emerging and Newly Identified Health Risks 
2015). In addition there is a preference for placing tooth-colored materials over dental amalgam 
(Bakhurji et al. 2019). Indeed, studies of U.S. dentists since 2014 found a substantial decline in mercury 
exposure from 1976 when the average level exceeded 20 micrograms per liter urine to 2012 when the 
average was less than 2 micrograms per liter for the reasons described above. On average, dentists 
were still exposed to more mercury than the general population but only by about 1 microgram per 
liter  (Anglen et al. 2015; Goodrich et al. 2016).  
The FDA found too many confounding variables and significant weaknesses in the studies 
reviewed to draw a conclusion about the neurobehavioral effects of mercury exposure on dental 
professionals, including the presence of other chemicals used in dental clinics (National Center for 
Toxicological Research and U.S. Food and Drug Administration 2009). A 2015 study found an 
association between tremor and urinary mercury levels and cumulative mercury exposure. The study is 
based on a convenience sample of dentists, so there may be selection bias in that some dentists were 
perhaps more motivated to participate than others or less able to participate based on health status. 
Furthermore, the authors did not have access to data on fish consumption of the participants and other 
possible confounding variables. 
Occupational safety studies have uncovered poor adherence to safety guidelines. The SCENIHR 
review noted one study that found violations of environmental and personal safety standards in 67% and 
45%, respectively, of clinics visited (Ritchie et al. 2004). Some recent studies also revealed violations of 
occupational safety regulations and indicated the need for more training on the safe use of dental 
amalgam, properly ventilated dental clinics and oversight (Jamil et al. 2016; Khwaja Mahmood et al. 
2016). The study by Khwaja and colleagues also highlighted the fact that there is still a high level of 
dental amalgam use among dentists in Pakistan, even in children and pregnant women and use can vary 
dramatically by location (Khwaja Mahmood et al. 2016). The FDI and WHO recommend using proper 
personal protective equipment and techniques and monitoring of mercury vapor levels in dental clinics 
 
to minimize exposure of dental personnel to mercury vapor (WHO Consensus Statement on Dental 
Amalgam  1997), which is especially important for dentists who will continue to place high amounts of 
amalgam fillings. These data also reiterate the need for prevention to reduce the need for amalgam in 
the first place.  
Since 2014, two studies in Taiwan using national insurance claims data on the neurological 
effects of dental amalgam warrant further investigation. The first study found that women with dental 
amalgam fillings had a higher overall risk of having Alzheimer’s Disease than women without dental 
amalgam fillings after adjusting for age, location and income (Sun et al. 2015), and the second found that 
people with dental amalgam fillings had a greater risk of having Parkinson’s Disease (Hsu et al. 2016). 
Neither study include a “pure” control group as the analysis was conducted from claims data, so the 
authors could not examine patients to ensure control group members had not received fillings before 
the beginning of the study date. Furthermore, the authors did not account for fish consumption (a 
source of methyl mercury). It is possible that once these factors are accounted for, the difference 
between the study and control groups would disappear. In particular, Hsu and colleagues’ study on 
Parkinson’s Disease noted that most patients were diagnosed two years after receiving dental treatment 
and that “it is unlikely that mercury would induce [Parkinson’s Disease] in such a short time.” The 
authors concluded that the study was unable to establish a causal association (Hsu et al. 2016). 
These recent studies on associations between neurological health effects on dentists and the 
general population provide important contributions and directions for future studies that should address 
these limitations and provide more conclusive results but are not on their own sufficient to establish a 
causal relationship between dental amalgam fillings and Alzheimer’s or Parkinson’s Disease. 
 
Mercury and the Environment – the Minamata Convention 
Over 100 countries have ratified the Minamata Convention on Mercury and agreed to 
provisions to protect the environment from mercury emission to land, air and water, including phasing 
 
down the use of dental amalgam. IADR agreed to promote research into alternative restorative 
materials and has been active in this regard. IADR calls on parties to the Convention to invest in 
research and development to accelerate the clinical use of new restorative dental materials. IADR 
especially supports the provision for countries to increase oral disease prevention efforts to reduce the 
need for any kind of restorative material in the first place, as the global pervasiveness of oral diseases 
will continue to slow the phase-down. According to the treaty, new measures that include the phase-




Based on the best available evidence, IADR affirms the safety of dental amalgam for the general 
population without allergies to amalgam components or severe renal diseases. IADR supports 
maintaining its availability as the best restorative option when alternatives are less than optimal based on 
clinical, economic or practical reasons. 
IADR supports the phase-down strategy described in the Minamata Convention on Mercury. 
Consistent with the recommendations of the treaty, IADR emphasizes the need, firstly, for increased 
oral disease prevention efforts to reduce the need for any kind of restorative material, and secondly, for 
further research on new biocompatible and environmentally-friendly restorative materials and 
approaches that are proven to have equal or improved long term clinical longevity and cost effectiveness 
when compared to amalgam restorations. 
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